Table 1.
Subject's drugs | Dilution ratio | Crude drug concentration (μg/mL) | Solid content concentration (mg/mL) | Results(4 compound pores) | |||
---|---|---|---|---|---|---|---|
RDNI | 20 | 130.000 | 3.023 | + | + | + | + |
40 | 65.000 | 1.511 | + | + | + | + | |
80 | 32.500 | 0.756 | + | + | + | + | |
160 | 16.250 | 0.378 | + | + | + | + | |
320 | 8.125 | 0.189 | + | + | + | + | |
640 | 4.063 | 0.094 | + | + | + | + | |
1280 | 2.031 | 0.047 | + | + | – | – | |
2560 | 1.016 | 0.024 | – | – | – | – | |
Control | 200 μL DMEM | – | – | – | – |
“+" means that the cells have CPE changes, "-" means that the cells have no CPE changes or was in normal cell morphology.